Rational study endpoint(s) for preoperative trials in pancreatic cancer: pathologic response rate, margin negative resection, overall survival or 'all of the above'? Ann Surg Oncol 2013 Nov;20(12):3712-4
Date
08/15/2013Pubmed ID
23943023DOI
10.1245/s10434-013-3165-5Scopus ID
2-s2.0-84886100127 (requires institutional sign-in at Scopus site) 5 CitationsAuthor List
Varadhachary GR, Evans DBAuthor
Douglas B. Evans MD Chair, Professor in the Surgery department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdenocarcinomaAntineoplastic Combined Chemotherapy Protocols
Carcinoma, Pancreatic Ductal
Female
Humans
Male
Neoplasm Recurrence, Local
Pancreatic Neoplasms
